Clinical Trial Update: Randomized Control Trial Copper Intrauterine Device and Depo-medroxyprogesterone Acetate (DMPA) of HIV+ Women in Malawi [NA]

View source ↗

Summary

A completed randomized trial compared a copper intrauterine device with Depo-medroxyprogesterone acetate for contraception in HIV-positive women in Malawi.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Copper-containing intrauterine device (copper intrauterine device)
• Depo-medroxyprogesterone acetate (DMPA) (depot medroxyprogesterone acetate)

Snippet

Sponsor: Emory University | Conditions: HIV | NA | Status: COMPLETED